Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) reached a new 52-week low on Monday . The company traded as low as $27.30 and last traded at $27.5270, with a volume of 98418 shares traded. The stock had previously closed at $29.06.
Analyst Ratings Changes
Several research firms recently issued reports on TRUP. Wall Street Zen cut shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Piper Sandler cut their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a report on Friday, February 13th. Stifel Nicolaus decreased their price objective on Trupanion from $38.00 to $35.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Weiss Ratings raised Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 17th. Finally, Cantor Fitzgerald decreased their price target on Trupanion from $50.00 to $42.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 14th. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $45.50.
View Our Latest Analysis on TRUP
Trupanion Stock Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its earnings results on Thursday, February 12th. The financial services provider reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.01). Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The business had revenue of $376.85 million for the quarter, compared to analyst estimates of $375.89 million. During the same period last year, the business posted $0.04 EPS. Trupanion’s revenue was up 11.7% on a year-over-year basis. As a group, research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.
Insider Transactions at Trupanion
In other Trupanion news, CEO Margaret Tooth sold 9,605 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $37.88, for a total transaction of $363,837.40. Following the transaction, the chief executive officer owned 150,294 shares in the company, valued at approximately $5,693,136.72. The trade was a 6.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO John R. Gallagher sold 6,383 shares of the company’s stock in a transaction on Friday, November 28th. The stock was sold at an average price of $34.82, for a total value of $222,256.06. Following the transaction, the chief operating officer directly owned 32,721 shares in the company, valued at $1,139,345.22. This represents a 16.32% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 16,848 shares of company stock worth $615,858. Corporate insiders own 5.42% of the company’s stock.
Hedge Funds Weigh In On Trupanion
Several institutional investors and hedge funds have recently modified their holdings of TRUP. Federated Hermes Inc. purchased a new position in Trupanion during the third quarter worth about $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Trupanion during the 3rd quarter valued at about $39,000. Nisa Investment Advisors LLC increased its stake in shares of Trupanion by 44.1% during the 2nd quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock valued at $54,000 after acquiring an additional 300 shares during the last quarter. Kemnay Advisory Services Inc. purchased a new position in shares of Trupanion during the 4th quarter worth about $64,000. Finally, Kelleher Financial Advisors acquired a new stake in shares of Trupanion in the third quarter worth approximately $74,000.
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Recommended Stories
- Five stocks we like better than Trupanion
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
